Detalhe da pesquisa
1.
Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial.
Blood
; 142(14): 1208-1218, 2023 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366170
2.
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
Blood
; 142(22): 1871-1878, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494698
3.
How I approach smoldering multiple myeloma.
Blood
; 140(8): 828-838, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576526
4.
Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
Am J Hematol
; 99(2): 309-324, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095141
5.
Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study.
Clin Chem Lab Med
; 62(3): 464-471, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37747270
6.
Historical Perspective of High-Dose Therapy Followed by Autologous Stem Cell Transplantation in Multiple Myeloma.
Acta Haematol
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710160
7.
Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma.
Cancer
; 129(3): 385-392, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413412
8.
MicroRNA and long non-coding RNA analysis in IgM monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis.
Haematologica
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058213
9.
Immunoglobulin Light Chain Amyloidosis: Diagnosis and Risk Assessment.
J Natl Compr Canc Netw
; 21(1): 83-90, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630897
10.
Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti-CD38 monoclonal antibody.
Eur J Haematol
; 111(2): 318-321, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37209032
11.
Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management.
Am J Hematol
; 98(2): 348-358, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588395
12.
Microvascular cardiac amyloidosis-Cardiac involvement of amyloidosis presenting as typical chest pain.
Am J Hematol
; 98(12): 1963-1966, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37878285
13.
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
Am J Hematol
; 98(3): 432-439, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588384
14.
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
Am J Hematol
; 98(3): 413-420, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588396
15.
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
Am J Hematol
; 98(8): 1277-1285, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334773
16.
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
Am J Hematol
; 98(10): 1540-1549, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421603
17.
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
Am J Hematol
; 98(1): 49-55, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226510
18.
Impact of belantamab mafodotin-induced ocular toxicity on outcomes of patients with advanced multiple myeloma.
Br J Haematol
; 199(1): 95-99, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35694818
19.
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series.
Am J Kidney Dis
; 79(2): 202-216, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175375
20.
Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
Am J Hematol
; 97(6): 818-829, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429180